TOI vs. ANRO
TOI (The Oncology Institute, Inc.) and ANRO (Alto Neuroscience, Inc) are both stocks. Both are in the Healthcare sector — TOI in Medical Care Facilities, ANRO in Biotechnology. Over the past year, TOI returned 119.65% vs 922.59% for ANRO. At a 0.12 correlation, their price movements are largely independent.
Performance
TOI vs. ANRO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TOI achieves a 41.29% return, which is significantly higher than ANRO's 37.30% return.
TOI
- 1D
- 0.40%
- 1M
- 9.59%
- YTD
- 41.29%
- 6M
- 48.82%
- 1Y
- 119.65%
- 3Y*
- 107.87%
- 5Y*
- —
- 10Y*
- —
ANRO
- 1D
- 6.59%
- 1M
- 15.17%
- YTD
- 37.30%
- 6M
- 24.31%
- 1Y
- 922.59%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TOI vs. ANRO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
TOI The Oncology Institute, Inc. | 41.29% | 1,052.10% | -85.42% |
ANRO Alto Neuroscience, Inc | 37.30% | 320.80% | -80.77% |
Correlation
The correlation between TOI and ANRO is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Feb 2, 2024 | 0.12 |
The correlation between TOI and ANRO shifts across timeframes, from 0.12 (all time) to 0.27 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
TOI:
$5.12B
ANRO:
$803.90M
TOI:
-$0.04
ANRO:
-$2.50
TOI:
$545.76M
ANRO:
$0.00
TOI:
$52.24M
ANRO:
-$421.00K
TOI:
-$21.81M
ANRO:
-$74.36M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TOI vs. ANRO — Risk / Return Rank
TOI
ANRO
TOI vs. ANRO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Oncology Institute, Inc. (TOI) and Alto Neuroscience, Inc (ANRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TOI | ANRO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -5.76 | ||
| Sortino ratioReturn per unit of downside risk | -3.33 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.72 | -0.45 |
| Calmar ratioReturn relative to maximum drawdown | 2.42 | 27.26 | -24.84 |
| Martin ratioReturn relative to average drawdown | 4.86 | 71.06 | -66.20 |
Loading charts...
Drawdowns
TOI vs. ANRO - Drawdown Comparison
The maximum TOI drawdown since its inception was -98.79%, which is greater than ANRO's maximum drawdown of -91.82%. Use the drawdown chart below to compare losses from any high point for TOI and ANRO.
Loading charts...
Drawdown Indicators
| TOI | ANRO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.79% | -91.82% | -6.97% |
Max Drawdown (1Y)Largest decline over 1 year | -49.79% | -34.20% | -15.59% |
Max Drawdown (3Y)Largest decline over 3 years | -94.82% | — | — |
Current DrawdownCurrent decline from peak | -53.90% | -11.83% | -42.07% |
Average DrawdownAverage peak-to-trough decline | -73.98% | -53.23% | -20.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.70% | 13.09% | +11.61% |
Volatility
TOI vs. ANRO - Volatility Comparison
The current volatility for The Oncology Institute, Inc. (TOI) is 21.02%, while Alto Neuroscience, Inc (ANRO) has a volatility of 24.73%. This indicates that TOI experiences smaller price fluctuations and is considered to be less risky than ANRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TOI | ANRO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.02% | 24.73% | -3.71% |
Volatility (6M)Calculated over the trailing 6-month period | 50.61% | 54.88% | -4.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.82% | 128.63% | -47.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 113.02% | 115.34% | -2.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 113.02% | 115.34% | -2.32% |
Dividends
TOI vs. ANRO - Dividend Comparison
Neither TOI nor ANRO has paid dividends to shareholders.
Financials
TOI vs. ANRO - Financials Comparison
This section allows you to compare key financial metrics between The Oncology Institute, Inc. and Alto Neuroscience, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TOI and ANRO have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANRO has higher volatility (24.73%) compared to TOI (21.02%). In terms of maximum drawdown, TOI dropped -98.79% vs ANRO's -91.82%.
ANRO currently has the higher Sharpe Ratio (7.25 vs 1.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TOI and ANRO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer